Bradley Canino
Stock Analyst at Stifel
(1.55)
# 3,481
Out of 5,154 analysts
82
Total ratings
32.88%
Success rate
-4.41%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Bradley Canino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JANX Janux Therapeutics | Maintains: Buy | $46 → $38 | $13.84 | +174.57% | 4 | Dec 2, 2025 | |
| SNDX Syndax Pharmaceuticals | Reinstates: Buy | $44 | $22.07 | +99.37% | 7 | Sep 10, 2025 | |
| BDTX Black Diamond Therapeutics | Maintains: Buy | $16 → $15 | $2.15 | +597.67% | 5 | Mar 7, 2025 | |
| ALXO ALX Oncology Holdings | Maintains: Hold | $3 → $1.5 | $2.21 | -32.13% | 8 | Mar 7, 2025 | |
| CGEM Cullinan Therapeutics | Maintains: Buy | $23 → $19 | $15.74 | +20.71% | 2 | Feb 28, 2025 | |
| RLAY Relay Therapeutics | Maintains: Buy | $27 → $23 | $9.89 | +132.56% | 5 | Feb 27, 2025 | |
| ARVN Arvinas | Maintains: Buy | $63 → $51 | $13.60 | +275.00% | 6 | Feb 12, 2025 | |
| KURA Kura Oncology | Downgrades: Hold | $26 → $19 | $8.96 | +112.05% | 6 | Oct 14, 2024 | |
| CELC Celcuity | Maintains: Buy | $39 → $42 | $115.00 | -63.48% | 4 | Oct 7, 2024 | |
| SMMT Summit Therapeutics | Maintains: Buy | $25 → $40 | $15.11 | +164.73% | 4 | Sep 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $135 | $99.41 | +35.80% | 4 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $13.71 | +45.88% | 1 | Sep 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.37 | +629.93% | 1 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $10 | $2.30 | +335.73% | 17 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $3.04 | +360.53% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $55 | $83.49 | -34.12% | 4 | Feb 23, 2024 |
Janux Therapeutics
Dec 2, 2025
Maintains: Buy
Price Target: $46 → $38
Current: $13.84
Upside: +174.57%
Syndax Pharmaceuticals
Sep 10, 2025
Reinstates: Buy
Price Target: $44
Current: $22.07
Upside: +99.37%
Black Diamond Therapeutics
Mar 7, 2025
Maintains: Buy
Price Target: $16 → $15
Current: $2.15
Upside: +597.67%
ALX Oncology Holdings
Mar 7, 2025
Maintains: Hold
Price Target: $3 → $1.5
Current: $2.21
Upside: -32.13%
Cullinan Therapeutics
Feb 28, 2025
Maintains: Buy
Price Target: $23 → $19
Current: $15.74
Upside: +20.71%
Relay Therapeutics
Feb 27, 2025
Maintains: Buy
Price Target: $27 → $23
Current: $9.89
Upside: +132.56%
Arvinas
Feb 12, 2025
Maintains: Buy
Price Target: $63 → $51
Current: $13.60
Upside: +275.00%
Kura Oncology
Oct 14, 2024
Downgrades: Hold
Price Target: $26 → $19
Current: $8.96
Upside: +112.05%
Celcuity
Oct 7, 2024
Maintains: Buy
Price Target: $39 → $42
Current: $115.00
Upside: -63.48%
Summit Therapeutics
Sep 25, 2024
Maintains: Buy
Price Target: $25 → $40
Current: $15.11
Upside: +164.73%
Sep 16, 2024
Maintains: Buy
Price Target: $115 → $135
Current: $99.41
Upside: +35.80%
Sep 6, 2024
Initiates: Buy
Price Target: $20
Current: $13.71
Upside: +45.88%
Aug 8, 2024
Initiates: Buy
Price Target: $10
Current: $1.37
Upside: +629.93%
Jun 18, 2024
Maintains: Buy
Price Target: $32 → $10
Current: $2.30
Upside: +335.73%
May 9, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $3.04
Upside: +360.53%
Feb 23, 2024
Maintains: Buy
Price Target: $35 → $55
Current: $83.49
Upside: -34.12%